Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
The Trouble With KRAS - Cancer Commons
Oncogenic KRAS Drives Immune Suppression in Colorectal Cancer - ScienceDirect
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
The mutation distribution of KRAS/NRAS/BRAF in (A) colon cancer, (B)... | Download Scientific Diagram
KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Frequencies of KRAS mutations measured using methods with different... | Download Scientific Diagram
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Colorectal Cancer
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
